Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-17

Clinical Trial Update: IMX-150 Cream for Diabetic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of IMX-150 Cream for diabetic peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMX-150 Cream

Snippet

Sponsor: Procris Pharmaceuticals | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED